Side-by-side comparison of AI visibility scores, market position, and capabilities
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Zurich industrial automation (NYSE: ABB) at $2.3B robotics revenue divesting to SoftBank for $5.375B (closing mid-to-late 2026); 140+ year history refocusing on electrification and motion control competing with Siemens for industrial automation.
ABB Ltd is a Zurich, Switzerland-headquartered industrial technology company — publicly traded on the New York Stock Exchange (NYSE: ABB) and SIX Swiss Exchange — providing electrification, motion control, process automation, and (pending divestiture) robotics solutions to utilities, industrial manufacturers, transportation, and infrastructure operators globally with approximately 110,000 employees. Formed in 1988 through the merger of Sweden's ASEA (founded 1883, launched the IRB 6 industrial robot in 1974) and Switzerland's Brown Boveri (founded 1891), ABB is undergoing a major strategic transformation: in 2025, ABB announced the divestiture of its ABB Robotics & Discrete Automation division (2024 revenue $2.3 billion, ~7,000 employees) to SoftBank Group Corp. for $5.375 billion, with the transaction expected to close mid-to-late 2026 — separating the robotics business to focus ABB on core electrification and motion segments.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.